Viking Therapeutics Inc
VKTX
NASDAQ
Biotechnology
$33.19
USD
+0.25 (+0.76%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.93B
Volume 1.2M
Price Target
$89.00 – $89.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $89.00 and a min estimate of $89.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$89.00
-$20.0 vs prior
Implied Upside
+168.2%
-60.3% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Daniel Brims | Lake Street | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
ARQT
Arcutis Biotherapeutics Inc
$26.19
▲ +1.4%
RLAY
Relay Therapeutics Inc
$19.86
▼ -0.3%
CLDX
Celldex Therapeutics Inc
$41.95
▼ -1.6%
DNLI
Denali Therapeutics Inc
$24.40
▼ -1.7%
VCYT
Veracyte Inc
$41.25
▼ -3.2%
LEGN
Legend Biotech Corp
$20.37
▲ +0.5%
IDYA
IDEAYA Biosciences Inc
$36.30
▼ -1.0%
TNGX
Tango Therapeutics Inc
$25.60
▼ -0.2%